Global Anticoagulant Reversal Drugs Market Forecast to 2027 – COVID-19 Impact and Analysis – ResearchAndMarkets.com

Global Anticoagulant Reversal Drugs Market Forecast to 2027 – COVID-19 Impact and Analysis – ResearchAndMarkets.com




Global Anticoagulant Reversal Drugs Market Forecast to 2027 – COVID-19 Impact and Analysis – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Anticoagulant Reversal Drugs Market Forecast to 2027 – COVID-19 Impact and Global Analysis By Product, and Distribution channel and Geography” report has been added to ResearchAndMarkets.com’s offering.

According to this report the global anticoagulant reversal drugs market is expected to reach US$ 2,276.54 million in 2027 from US$ 922.55 in 2019; it is estimated to grow at a CAGR of 12.6% from 2020 to 2027. The report highlights trends prevailing in the global anticoagulant reversal drugs market, and the factors governing the market growth.

Based on distribution channel, the anticoagulant reversal drugs market is segmented into hospital pharmacies, retail pharmacies, and others. The hospital pharmacies segment held the largest share of the market in 2019, and is estimated to register the highest CAGR in the market during the forecast period. Hospital pharmacies offer complex and specialized medicines, which may not be available in a retail pharmacy. It ensures the availability of right medication, in the right dose and at the right time. These factors are expected to contribute to the growth of the market during the forecast period.

The global anticoagulant reversal drugs market growth is mainly attributed to the rising prevalence of atrial fibrillation (AFib) and stroke. However, the high cost of anticoagulant reversal drugs is restricting the market growth.

Reasons to Buy

  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the anticoagulant reversal drugs market.
  • Highlights key business priorities in order to assist companies to realign their business strategies.
  • The key findings and recommendations highlight crucial progressive industry trends in the global anticoagulant reversal drugs market, thereby allowing players across the value chain to develop effective long-term strategies.
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
  • Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

Market Dynamics

Drivers

  • Rise in Prevalence of Atrial Fibrillation (AFib)
  • Increase in Prevalence of Stroke

Restraints

  • High Cost of Anticoagulant Reversal Drugs

Opportunities

  • Increasing Research Activities on Anticoagulant Reversal Drugs

Future Trends

  • Development and Launch of Innovative Products

Companies Mentioned

  • Boehringer Ingelheim International GmbH
  • Pfizer Inc.
  • Octapharma AG
  • AMAG PHARMACEUTICALS, INC.
  • Fresenius Kabi AG
  • Alexion Pharmaceuticals, Inc. (Portola Pharmaceuticals)
  • CSL Limited
  • China Biologic Products, Inc
  • Grifols, S.A.
  • Shanghai RAAS Blood Products Co.

For more information about this report visit https://www.researchandmarkets.com/r/zazquu

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900